Private investment firm SYON CAPITAL LLC focuses on growth-stage technology and healthcare investments, deploying structured equity and venture-style capital to scale market-facing businesses. The firm emphasizes operational partnership, board-level governance, and follow-on capital to drive revenue acceleration and strategic exits. Typical engagement spans Series A to late-growth rounds with sector expertise in software, fintech, and life sciences.
Private investment firm SYON CAPITAL LLC focuses on growth-stage technology and healthcare investments, deploying structured equity and venture-style capital to scale market-facing businesses. The firm emphasizes operational partnership, board-level governance, and follow-on capital to drive revenue acceleration and strategic exits. Typical engagement spans Series A to late-growth rounds with sector expertise in software, fintech, and life sciences.
Targets growth-stage technology and healthcare companies, allocating structured equity and venture-style capital to accelerate revenue and de-risk scale. Investment style blends active board governance, operational partnership, and staged follow-on commitments to protect upside while managing dilution risk. Underwriting emphasizes durable GTM models, regulatory defensibility in life sciences, and fintech compliance moats. Typical holding periods span multi-year growth cycles with exit orientation toward strategic sales or growth IPOs; portfolio construction balances concentrated conviction positions with reserve capital for winners.
Targets growth-stage technology and healthcare companies, allocating structured equity and venture-style capital to accelerate revenue and de-risk scale. Investment style blends active board governance, operational partnership, and staged follow-on commitments to protect upside while managing dilution risk. Underwriting emphasizes durable GTM models, regulatory defensibility in life sciences, and fintech compliance moats. Typical holding periods span multi-year growth cycles with exit orientation toward strategic sales or growth IPOs; portfolio construction balances concentrated conviction positions with reserve capital for winners.
| Trades 6548 | Longs Won 4341/6548 66% | Profit Factor 5.61 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $827,350.67 |
| Average Win $154,266.3 | Best Trade (Mar 31) $39.14M | Sharpe Ratio -10.33 |
| Average Loss -$54,044.59 | Worst Trade (Jul 17) -$18.84M | Z-Score 29.13 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1m 2w 6d | Expectancy $84,073.42 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 40,000 | 36,000 | 32,000 | 28,000 | 24,000 | 20,000 | 16,000 | 12,000 | 8,000 | 4,000 |